Article ; Online: Focus on clinical outcomes of "Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial".
International journal of antimicrobial agents
2021 Volume 57, Issue 1, Page(s) 106175
MeSH term(s) | Anti-Bacterial Agents/therapeutic use ; Antimalarials/therapeutic use ; Antiviral Agents/therapeutic use ; Azithromycin/therapeutic use ; COVID-19/drug therapy ; COVID-19/virology ; Clinical Trials as Topic ; Drug Combinations ; Drug Repositioning ; Humans ; Hydroxychloroquine/therapeutic use ; SARS-CoV-2/pathogenicity ; Uncertainty |
---|---|
Chemical Substances | Anti-Bacterial Agents ; Antimalarials ; Antiviral Agents ; Drug Combinations ; Hydroxychloroquine (4QWG6N8QKH) ; Azithromycin (83905-01-5) |
Language | English |
Publishing date | 2021-01-06 |
Publishing country | Netherlands |
Document type | Letter |
ZDB-ID | 1093977-5 |
ISSN | 1872-7913 ; 0924-8579 |
ISSN (online) | 1872-7913 |
ISSN | 0924-8579 |
DOI | 10.1016/j.ijantimicag.2020.106175 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
Zs.A 3368: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular Jg. 1995 - 2021: Lesesall (2.OG) ab Jg. 2022: Lesesaal (EG) |
|||
Zs.MO 500: Show issues |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.